News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Wall Street Doubt Eli Lilly and Company (LLY), Pfizer Inc. (PFE) Alzheimer's Meds


6/20/2012 7:22:02 AM

Institutional investors doubt that treatments for Alzheimer's disease being developed by Pfizer Inc and Eli Lilly will achieve the main goals of their ongoing late-stage trials, but hopes are running far higher for the Pfizer drug, according to a survey by ISI Group Inc. Results from the survey of 146 investors were released late on Tuesday by Mark Schoenebaum, a pharmaceutical analyst for the investment research services group. Wall Street is eagerly awaiting results of the trials and expects huge potential sales if either of the medicines proves able to arrest the progression of the memory-robbing disease.

Read at Reuters
Read at Pharmalot


comments powered by Disqus
Reuters
Pharmalot
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES